scholarly journals Malignant primary pericardial mesothelioma presenting as effusive constrictive pericarditis: a case report study

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Amir Savarrakhsh ◽  
Azin Vakilpour ◽  
Sam Zeraatian-Nejad Davani ◽  
Mahyar Daskareh ◽  
Mahdieh Morsaghian ◽  
...  

Abstract Background Primary pericardial mesothelioma (PPM) is a rare malignancy with a high prevalence of mortality. The diagnosis is usually challenging using a variety of imaging modalities and invasive procedures and is generally performed at the later stages of the disease or in autopsy. This case study points to an unconventional presentation of PPM and the challenges in diagnosing this rare mortal malignancy. Case presentation This study presents a 44-year-old woman with no remarkable medical history with an initial diagnosis of effusive constrictive pericarditis at first hospitalization. Imaging evaluations, including transthoracic echocardiography and chest computed tomography scan, demonstrated visible thickened pericardium, pericardial effusion, and mass-like lesions in pericardium and mediastinum. The definite diagnosis of primary pericardial mesothelioma was established after pericardiectomy and histopathology examinations. Chemotherapy with pemetrexed and carboplatin was administrated to the patient, and she has been through four cycles of chemotherapy with no complications to date. Conclusion Constrictive pericarditis is an uncommon presentation of PPM. Due to the high mortality rate and late presentation, difficulties and uncertainties in diagnosis, being aware of this rare malignant entity in different cardiac manifestations, particularly when there is no clear explanation or response to treatment in such conditions, is highly important.

2017 ◽  
Vol 02 (02) ◽  
pp. 046-048
Author(s):  
R Kumar ◽  
Sai Surabhi ◽  
◽  

AbstractPrimary pericardial mesothelioma is a rare and lethal tumor, with a reported prevalence of <0.002% [1]. Pleural and pericardial mesotheliomas, which are far more common are usually associated with exposure to asbestos. However, the cause of pericardial mesothelioma is less clear [2] and is influenced by other factors like genetic predisposition, immunological impairment, infection, radiation, dietary factors and recurrent serosal inflammation [3]. Clinical manifestations of the neoplasm include constrictive pericarditis, cardiac tamponade, and heart failure. Because of late presentation and few treatment approaches, primary pericardial mesothelioma carries a poor prognosis. In this paper, we present a case of primary pericardial mesothelioma in a 46 year female presenting as recurrent pericardial effusion along with constrictive pericarditis.


2015 ◽  
Vol 65 (10) ◽  
pp. A759
Author(s):  
Rajesh Tota-Maharaj ◽  
Salma Baksh ◽  
Amrit Thakoor ◽  
Vidarshi Muthukumarana ◽  
Jessica Dodge ◽  
...  

2021 ◽  
Vol 22 (9) ◽  
pp. 4480
Author(s):  
Maria Tziastoudi ◽  
Georgios Pissas ◽  
Georgios Raptis ◽  
Christos Cholevas ◽  
Theodoros Eleftheriadis ◽  
...  

Chronic kidney disease (CKD) is an important global public health problem due to its high prevalence and morbidity. Although the treatment of nephrology patients has changed considerably, ineffectiveness and side effects of medications represent a major issue. In an effort to elucidate the contribution of genetic variants located in several genes in the response to treatment of patients with CKD, we performed a systematic review and meta-analysis of all available pharmacogenetics studies. The association between genotype distribution and response to medication was examined using the dominant, recessive, and additive inheritance models. Subgroup analysis based on ethnicity was also performed. In total, 29 studies were included in the meta-analysis, which examined the association of 11 genes (16 polymorphisms) with the response to treatment regarding CKD. Among the 29 studies, 18 studies included patients with renal transplantation, 8 involved patients with nephrotic syndrome, and 3 studies included patients with lupus nephritis. The present meta-analysis provides strong evidence for the contribution of variants harbored in the ABCB1, IL-10, ITPA, MIF, and TNF genes that creates some genetic predisposition that reduces effectiveness or is associated with adverse events of medications used in CKD.


2012 ◽  
Vol 18 (3) ◽  
pp. 277-287 ◽  
Author(s):  
Faisal F. Syed ◽  
Mpiko Ntsekhe ◽  
Bongani M. Mayosi ◽  
Jae K. Oh

2019 ◽  
Vol 21 (11) ◽  
Author(s):  
William R. Miranda ◽  
Darrell B. Newman ◽  
Jae K. Oh

2019 ◽  
Vol 2019 ◽  
pp. 1-4
Author(s):  
Michael Beattie ◽  
Ramy Mansour ◽  
Derek Thigpin ◽  
Carolyn Haus

Primary gastric squamous cell carcinoma is a very rare disease. A 53-year-old male with history of hypertension, alcoholism, and nicotine abuse presented to the hospital after a syncopal episode. He complained of bloating abdominal pain, early satiety, and poor appetite. A CT of his abdomen and pelvis revealed a gastric mass with diffuse hepatic metastasis. A gastric mass was seen on upper endoscopy and biopsies revealed gastric squamous cell carcinoma. There was no involvement of the esophagus. This case should add to the limited literature and serve as a reminder that while this is a rare malignancy, it must be considered when evaluating a gastric mass.


Sign in / Sign up

Export Citation Format

Share Document